Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|October 10, 2023
IDWeek 2023 Features Leaders Spanning the Specialty's Expertise
Author(s)Grace Halsey
Advertisement
IDWeek 2023 plenary sessions and named lectures will cover topics ranging from a 20-year history of antibiotic stewardship and the current state of inequities in stewardship and infection control to role of artificial intelligence in the future of infectious disease.
Experts from leading US academic medical centers and esteemed colleagues who will serve as session moderators will focus on some of the most vexing issues facing the practice of infectious disease as well as potential bright spots and solutions. Click through the slides here for an introduction to these top thinkers and the title, day, and time of their sessions.
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections
2
4 FDA Decisions for Primary Care to Know from October 2026
3
The Future of HIV PrEP and One Step to Take Tomorrow
4
Why a Negative Endometrial Biopsy May Not End the Abnormal Bleeding Workup
5